-
Share
707 Posts.
78
01/02/19
15:54
Share
I am unconvinced about the residual value in the assets.
They have had such limited commercial interest in any of the "pipeline" drugs that I just question whether they actually have any worth.
I guess that they could prove me wrong, but the cash will likely run out before they can get a deal.
Merck is the only one with and interest and my bet is that they will buy all of the assets out of receivership for a song.
They do not need to bid for the company nor pay a premium in the absence of any other buyers.
I guess we will just have to wait and see.........
-